Ketamine for Rapid Antidepressant Treatment

Ketamine Nasal Spray Approved

FDA approves Johnson & Johnson’s ketamine-derived nasal spray for depression as stand-alone treatment

The announcement was welcome news for those with major depressive disorder, which affects an estimated 8.3% of the adult population.

CNN on MSN · 2d

FDA approves standalone use of J&J’s ketamine-derived depression treatment

The U.S. Food and Drug Administration expanded approval for Johnson & Johnson’s nasal spray, Spravato, to allow it to be used as a standalone treatment for patients with severe depression, the company said on Tuesday.

Too Old to Operate · 4d

Safety and Feasibility of Intranasal Ketamine in Depression Treatment

The following is a summary of “Intranasal racemic ketamine maintenance therapy for patients with treatment-resistant depression: a naturalistic feasibility study,” published in the January 2025 issue of Psychiatry by Halpape et al.

Hosted on MSN1h

How Ketamine Therapy Helps With Depression And PTSD

Exploring new treatment avenues has become crucial as mental health challenges such as depression and PTSD continue impacting ...

The Debrief11d

Mystical Feelings of Awe Amplify Ketamine’s Antidepressant Effects, Research Reveals

New research involving ketamine continues show that having a mystical experience is key to the effectiveness of psychedelic ...

RVA MAG20h

Can Ketamine Really Heal Trauma? Richmond Therapists Share Their Insights

This article explores insights from Richmond-area therapists on Ketamine-Assisted Psychotherapy (KAP) and EMDR therapy, focusing on their applications in treating trauma, CPTSD, and mental health ...

Controlled drug Ketamine a lifeline for patients with severe depression in S’pore

Ketamine therapy is now a mainstream prescription for treatment-resistant depression. Read more at straitstimes.com.

Results that may be inaccessible to you are currently showing.

Hide inaccessible results